Dow AgroSciences, Dualsystems Biotech Announce Profiling Agreement

Dow AgroSciences and Dualsystems Biotech announced a drug profiling agreement. Under the agreement, Dualsystems Biotech will use its drug profiling platform to identify molecular targets for an undisclosed small molecule lead candidate in Dow AgroSciences’ agrochemical discovery program. Dualsystems Biotech as a partner will contribute to the identification of new targets and elucidation of the mechanism of action of a novel class of compounds.

Dualsystems exploits the versatility of its platform technology by continuously expanding its international client base into all sectors of the life science industry.

"Dow AgroSciences is pleased to announce this new partnership with Dualsystems, an innovative leader in custom screening services,” said Vidyadhar B. Hegde, Ph.D., Director, Chemistry, Discovery Research, Dow AgroSciences. “This collaboration further expands our technology tool-box to accelerate the progress of Discovery efforts to develop novel solutions to meet the growing demands of our customers around the world.”

"As we offer our superior services in a highly competitive research area we are proud to have won this agreement from a prominent leader such as Dow AgroSciences,” said Daniel Auerbach, CEO – Operations, Dualsystems Biotech.